Tetracycline Hydrochloride description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Tetracycline Hydrochloride

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

TETRACYCLINE HYDROCHLORIDE DESCRIPTION


Tetracycline Hydrochloride




CLINICAL PHARMACOLOGY



Microbiology


Gram-negative Bacteria
















Gram-positive Bacteria






Other microorganisms














Susceptibility Testing


INDICATIONS & USAGE



  • ●     Upper respiratory tract infections caused by Streptococcus pyogenes, Streptococcus pneumoniae and Hemophilus influenzae. Note: Tetracycline should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible.
  • ●     Lower respiratory tract infections caused by Streptococcus pyogenes, Streptococcus pneumoniae, Mycoplasma pneumoniae (Eaton agent, and Klebsiella sp.)
  • ●     Skin and soft tissue infections caused by Streptococcus pyogenes, Staphylococcus aureaus. (Tetracyclines are not the drugs of choice in the treatment of any type of staphylococcal infections.)
  • ●     Infections caused by rickettsia including Rocky Mountain spotted fever, typhus group infections, Q fever, rickettsialpox.
  • ●     Psittacosis or ornithosis caused by Chlamydia Psittaci.
  • ●     Infections caused by Chlamydia trachomatis such as uncomplicated urethral, endocervical or rectal infections, inclusion conjunctivitis, trachoma, and lymphogranuloma venereum.
  • ●     Granuloma inquinale caused by Calymmatobacterium granulomatis.
  • ●     Relapsing fever caused by Borrelia sp.
  • ●     Bartonellosis caused by Bartonella bacilliformis.
  • ●     Chancroid caused by Hemophilus ducreyi.
  • ●     Tularemia caused by Francisella tularensis.
  • ●     Plaque caused by Yersinia pestis.
  • ●     Cholera caused by Vibrio cholerae.
  • ●     Brucellosis caused by Brucella species (tetracycline may be used in conjunction with an aminoglycoside).
  • ●     Infections due to Campylobacter fetus.
  • ●     As adjunctive therapy in intestinal amebiasis caused by Entamoeba histolytica.
  • ●     Urinary tract infections caused by susceptible strains of Escherichia coli, Klebsiella, etc.
  • ●     Other infections caused by susceptible gram-negative organisms such as E. coli, Enterobacter aerogenes, Shigella sp., Acinetobacter sp., Klebsiella sp., and Bacteroides sp.
  • ●     In severe acne, adjunctive therapy with tetracycline may be useful.

  • ●     Syphilis and yaws caused by Treponema pallidum and pertenue, respectively,
  • ●     Vincent's infection caused by Fusobacterium fusiforme,
  • ●     Infections caused by Neisseria gonorrhoeae,
  • ●     Anthrax caused by Bacillus anthracis,
  • ●     Infections due to Listeria monocytogenes,
  • ●     Actinomycosis caused by Actinomyces species,
  • ●     Infections due to Clostridium species.

TETRACYCLINE HYDROCHLORIDE CONTRAINDICATIONS



WARNINGS








PRECAUTIONS

General






INFORMATION FOR PATIENTS



LABORATORY TESTS




DRUG INTERACTIONS







CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY





PREGNANCY

Teratogenic Effects:

Pregnancy Category D


Nonteratogenic Effects:



LABOR & DELIVERY



NURSING MOTHERS



PEDIATRIC USE



TETRACYCLINE HYDROCHLORIDE ADVERSE REACTIONS

Gastrointestinal:


Teeth:
Skin:
Renal toxicity:
Liver:
Hypersensitivity reactions:
Blood:
Other:


OVERDOSAGE



DOSAGE & ADMINISTRATION

Adults


Children above eight years of age







Concomitant therapy







HOW SUPPLIED




STORAGE AND HANDLING





ANIMAL PHARMACOLOGY & OR TOXICOLOGY





PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Tetracycline Hydrochloride

Tetracycline Hydrochloride

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL













Tetracycline Hydrochloride

Tetracycline Hydrochloride CAPSULE

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:24236-404(NDC:0172-2416)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
TETRACYCLINE HYDROCHLORIDE TETRACYCLINE 250 mg

Inactive Ingredients

Ingredient Name Strength
D&C YELLOW NO. 10
FD&C BLUE NO. 1
FD&C BLUE NO. 2
FD&C RED NO. 40
FD&C YELLOW NO. 6
FERROSOFERRIC OXIDE
GELATIN
propylene glycol
SHELLAC
SILICON DIOXIDE
STARCH, CORN
STEARIC ACID
titanium dioxide

Product Characteristics

Color Size Imprint Code Shape
yellow 19 mm Z;2416 CAPSULE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:24236-404-02 30 in 1 BLISTER PACK
2 NDC:24236-404-06 28 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA060704 2011-12-13


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.